The National Archives and Records Administration (NARA) is being sued to turn over approximately 5,400 emails connected to then-Vice President Joe Biden’s pseudonym accounts to forward government information and business with his son, Hunter Biden, and others.

Southeastern Legal Foundation (SLF) filed a federal lawsuit against the agency on Monday after NARA officials confirmed with other sources that Biden used three personal pseudonym email accounts under the names Robin Ware, Robert L. Peters, and JRB Ware but has since “dragged its feet and still has not produced a single email,” the law group said in a news release.

“All too often, public officials abuse their power by using it for their personal or political benefit,” Kimberly Hermann, general counsel for the legal foundation, said. “When they do, many seek to hide it. The only way to preserve governmental integrity is for NARA to release Biden’s nearly 5,400 emails to SLF and thus the public. The American public deserves to know what is in them.”

The group identified thousands of potentially responsive records from NARA after submitting a Freedom of Information Act request in June in its latest effort to investigate allegations that Biden communicated with Hunter regarding his foreign business dealings dating back to 2017.

SLF attorneys first asked the federal agency to release Biden’s emails in 2021. However, NARA officials reportedly failed to comply, claiming it did not have custody of his records before January 2017 and could only make the emails public in January 2022.

“Public transparency is the most vital check the citizens have for holding our political class accountable,” Braden Boucek, litigation director for SLF, said. “After over a year of trying to work with NARA, its continued unreasonable delays have forced SLF to file this lawsuit.”

The lawsuit comes after House Republicans began looking into President Biden’s alleged use of a fake name to mask his identity as they ramp up an investigation into the first family.

Oversight Chairman James Comer (R-KY) sent a letter to NARA requesting all unredacted records and communications regarding Biden’s official duties as vice president that overlapped Hunter’s activities with Ukrainian energy company Burisma Holdings, which employed the then-vice president’s son on its board for several years. The lucrative arrangement has drawn scrutiny by investigators in addition to other foreign business ventures. Joe Biden served as vice president from January 2009 to January 2017.

In particular, Comer said he seeks documents in which the elder Biden allegedly used a pseudonym; his son’s former business partners Hunter Biden, Eric Schwerin, or Devon Archer are copied; and all drafts of then-Vice President Biden’s speech delivered to Ukraine’s parliament in December 2015.

“The Committee is concerned that foreign nationals have sought access and influence by engaging in lucrative business relationships with high-profile political figures’ immediate family members, including members of the Biden family,” Comer wrote.

A NARA spokesperson told The Daily Wire that the agency received the request and will respond in accordance with the requirements of the Presidential Records Act.

Daniel Chaitin contributed to this report.

Doctors in New York City are scrambling to find answers as a a cheap, flesh-rotting horse tranquilizer floods the city’s illegal drug market.

Xylazine, called “tranq” on the street, is mass-manufactured in China and has recently proliferated on the streets New York as well as San Francisco and Philadelphia.

The “zombie drug” causes skin lesions that look like flesh is being eaten off, sometimes down to the bone, and can slow a person’s heart and breathing until they stop, leaving users catatonic or dead.

Drug dealers frequently mix Xylazine with fentanyl to prolong the high, creating a potentially deadly cocktail, but “tranq” is often mixed with other drugs like meth and cocaine as well, meaning users often take Xylazine unknowingly.

“Tranq” recently hit the streets of New York with “astonishing” speed, according to law enforcement.

Dr. Paolo Coppola, the board-certified co-founder of Victory Recovery Partners near Oyster Bay on Long Island, said the situation gets much more complicated when tranq is involved.

“The clinical picture becomes much more diabolical, a lot harder to follow — a lot more can go wrong,” Coppola told the New York Post.

Meanwhile, Narcan, the emergency opioid reverse medicine, does not work on “tranq” since xylazine is not an opioid.

“When [an addict] uses a speedball of cocaine and heroin, we can deal with that no problem. You reverse the heroin so they start breathing again and you wait for the cocaine to finish up,” Coppola said.

“Xylazine doesn’t work that way,” the doctor told the Post. “When they come to the emergency room, you fully expect them to wake up when you push the Narcan … but all of a sudden it’s not really working, they’re not waking up.”

Coppola said doctors often have to use different drugs to help patients on “tranq” whose blood pressure or heart rate is sinking. Addicts can also be addicted to Xylazine without knowing it until they try to get clean and the withdrawal leaves them anxious and irritable.

Dr. Steve Salvatore, Victory’s co-founder and president warned that because “tranq” is so cheap and prolongs the high, we are “going to be seeing a lot more of xylazine.”

“That’s why it’s become popular: Now, your high goes from one or two hours to more like four to five hours,” Dr. Steve Salvatore told the Post.

Xylazine has the Drug Enforcement Agency (DEA) alarmed as well.

The DEA said it has seized xylazine and fentanyl mixtures in 48 states. In 2022, the DEA found xylazine in about 23% of the fentanyl powder and 7% of the fentanyl pills seized by the agency.

In the three and a half years from January 2019 to June 2022, the number of fentanyl deaths each month that involved xylazine spiked from about 2.9% to 10.9% in 20 states and the District of Columbia, the Centers for Disease Control and Prevention (CDC) reported in June.

Because Xylazine was only ever intended for animal use, the drug is not a controlled substance federally or in New York. Several cities and states have moved to crack down on the drug, however.